Astec Lifesciences Ltd.
ShareASTEC Competitor Analysis
| ASTEC | UPL  | PIIND | SUMICHEM | BAYERCROP | |
|---|---|---|---|---|---|
Overview | |||||
| Current price (₹) As on 21 Nov, 2025, 02:09 PM | 782.40 0% | 748.00 0% | 3,432.20 0% | 449.80 0% | 4,562.80 0% |
| Market cap (₹ Cr) | 1,754 | 59,612 | 52,073 | 22,452 | 20,506 |
Past ReturnsAbsolute Returns Shown | |||||
| 1D | 1.91% | -1.75% | -2.38% | -1.55% | -0.11% |
| 1W | 6.01% | -0.12% | -3.64% | -4.1% | 1.05% |
| 1M | -8.1% | 11.58% | -2.14% | -12.91% | -8.87% |
| 3M | -21.54% | 6.48% | -8.92% | -22.71% | -18.43% |
| 6M | -8.88% | 20.83% | -7.29% | -15.39% | -10.85% |
| 1Y | -38.48% | 38.93% | -16.64% | -11.99% | -19.63% |
| 5Y | -31.05% | 80.7% | 42.2% | 61.96% | -8.93% |
Income StatementAnnual data as on 13 Dec 2025. All values in ₹ Cr. YoY growth displayed | |||||
| Sales | 381.3 -16.78% | 46,637 8.21% | 7,978 4.07% | 3,149 10.72% | 5,473 7.25% |
| OPM (%) | -17.11 -1247.24% | 16.13 54.8% | 26.18 2.31% | 19.34 19.83% | 12.33 -32.99% |
| PBT | -140.99 -128.32% | 1,301 170.51% | 2,138 13.48% | 680.24 35.25% | 707.4 -24.86% |
PAT | -134.71 -187.29% | 1,292 178.97% | 1,656 -0.9% | 506.44 36.97% | 568 -23.3% |
| Net Profit Margin | -35.33 -245.36% | 1.76 140.37% | 20.81 -5.15% | 16.09 23.77% | 10.38 -28.46% |
| EPS | -68.71 -187.13% | 10.62 166.42% | 109.43 -1.26% | 10.13 36.89% | 126.38 -23.3% |
Balance Sheet & Cash FlowAnnual data as on 13 Dec 2025. All values in ₹ Cr. YoY growth displayed | |||||
| Net Worth | 234.75 -36.37% | 29,213 17.76% | 10,157 16.33% | 2,901 18.8% | 2,850 0.04% |
| Total Assets | 881.42 -9.59% | 88,002 0.52% | 12,277 14.06% | 3,964 19.65% | 5,246 14.12% |
| Total Outside Liabilities | 646.68 6.71% | 58,789 -6.3% | 2,120 4.28% | 1,063 21.95% | 2,396 37.07% |
| Cash from Operating Activity | -8.4 -182.19% | 10,151 457.14% | 1,413 -30.6% | 452.73 -40.21% | 262 -72.47% |
| Cash from Investment Activity | -15.23 88.73% | -1,840 25.75% | -1,424 20.93% | -392.06 6.74% | 85.6 21300% |
| Cash from Financing Activity | 23.73 -81.01% | -4,793 -3022.56% | -286.5 -29.29% | -69.08 79.5% | -619.4 5.62% |
| Net Cash Flow | 0.1 -90% | 3,535 14829.17% | -294.2 -2231.88% | -8.4 -3130.77% | -271.8 -191.92% |
RatiosAnnual data as on 13 Dec 2025. | |||||
| PB | 5.64 | 1.73 | 5.12 | 9.61 | 7.76 |
| PE | N.A. | 66.46 | 31.37 | 44.42 | 34.61 |
| ROE (%) | -44.63 | 4.78 | 17.53 | 18.96 | 19.93 |
| Dividend Yield (%) | 0.19 | 0.80 | 0.47 | 0.27 | 2.74 |
| ROCE (%) | -12.63 | 10.05 | 22.70 | 25.68 | 25.42 |
